High Point, NC
Heart & ScienceRead Stories About Our People »
Our global network of pharmaceutical development and manufacturing facilities allows Thermo Fisher Scientific the collaboration and reach to ensure your project gets completed quickly and accurately.
Thermo Fisher Scientific has entered into a definitive agreement to acquire Brammer Bio, a leader in gene therapy. Find out what this means for Thermo Fisher and our CDMO capabilities.
Thermo Fisher Scientific’s Patheon and Fisher Clinical Services brands have joined together to create the most complete, end-to-end, truly integrated pharma services offering in the industry. Read more about our combined capabilities and learn how we can take your discovery from clinical to commercial.
25/03/2019BIO-Europe Spring 2019 This year’s event in Vienna will bring together the “who’s who” from the biotech, pharma and finance segments to allow delegates to meet more key decision makers in three days of partnering meetings than they could in a whole year.
02/04/2019Nicholas Hall’s 30th European Conference & CHC Training Academy Workshop April 2-4, 2019, Würzburg, Germany – With consumers becoming increasingly health conscious and ready to engage with their own health management, and technology such as AI and Big Data allowing us to deliver new and improved digital health & wellness tools, the consumer healthcare industry must be bolder and invest in digital to deliver additional… Read More
09/04/2019German Biotech Days April 9 – 10, 2019 – The DBT are a meeting place for more than 850 representatives from the worlds of business, science and government, including partners from funding institutions and public administration. Through a series of talks, panel discussions and breakfast sessions, the conference discusses the conditions for innovation in biotechnology and the wide… Read More